rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Ilan Ganot

Director

Company insider

Files Form 4 as: CEO & President, Solid Biosciences.

Every Form 4 they filed

In numbers

Trades disclosed
118
Buys
0
Sells
19
Bought
$0
Sold
$1.8M
Companies
1
Companies where not an officer
0
First trade
25 Jul 2018
Last trade
10 Jun 2026
Last filed
11 Jun 2026

Companies traded

Where they are an officer
SLDB Solid BiosciencesDirector, Officer · Biotechnology · last 10 Jun 20260 buys · 19 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
20Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
10 Jun 2026filed 11 Jun 2026SLDB Solid Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—77,500 at $0.00filing
10 Jun 2026filed 11 Jun 2026SLDB Solid Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—77,500 at $0.00filing
18 Feb 2026filed 18 Feb 2026SLDB Solid BiosciencesBiotechnologySEC FORM 4 Sold$15K2,658 at $5.82filing
18 Feb 2026filed 18 Feb 2026SLDB Solid BiosciencesBiotechnologySEC FORM 4 Sold$15K2,658 at $5.82filing
13 Feb 2026filed 18 Feb 2026SLDB Solid BiosciencesBiotechnologySEC FORM 4 Code M—4,861filing
13 Feb 2026filed 18 Feb 2026SLDB Solid Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code M—4,861 at $0.00filing
13 Feb 2026filed 18 Feb 2026SLDB Solid Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code M—4,861 at $0.00filing
13 Feb 2026filed 18 Feb 2026SLDB Solid BiosciencesBiotechnologySEC FORM 4 Code M—4,861filing
4 Feb 2026filed 6 Feb 2026SLDB Solid BiosciencesBiotechnologySEC FORM 4 Sold$46K7,205 at $6.44filing
4 Feb 2026filed 6 Feb 2026SLDB Solid BiosciencesBiotechnologySEC FORM 4 Sold$46K7,205 at $6.44filing
31 Jan 2026filed 2 Feb 2026SLDB Solid BiosciencesBiotechnologySEC FORM 4 Code M—15,000filing
31 Jan 2026filed 2 Feb 2026SLDB Solid Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code M—15,000 at $0.00filing
31 Jan 2026filed 2 Feb 2026SLDB Solid Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code M—15,000 at $0.00filing
31 Jan 2026filed 2 Feb 2026SLDB Solid BiosciencesBiotechnologySEC FORM 4 Code M—15,000filing
29 Jan 2026filed 2 Feb 2026SLDB Solid Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—70,900 at $0.00filing
29 Jan 2026filed 2 Feb 2026SLDB Solid Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—35,450 at $0.00filing
29 Jan 2026filed 2 Feb 2026SLDB Solid Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—70,900 at $0.00filing
29 Jan 2026filed 2 Feb 2026SLDB Solid Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—35,450 at $0.00filing
28 Jan 2026filed 30 Jan 2026SLDB Solid BiosciencesBiotechnologySEC FORM 4 Sold$1,259191 at $6.59filing
28 Jan 2026filed 30 Jan 2026SLDB Solid BiosciencesBiotechnologySEC FORM 4 Sold$1,259191 at $6.59filing

Sectors

Health Care19

Buys in green, sells in red, by the company’s sector.

Related people

Gabriel BrooksChief Medical Officer · Chief Medical Officer at Solid Biosciences, filing Form 4 there in the last year
Ian F. SmithDirector · Director at Solid Biosciences, filing Form 4 there in the last year
Adam Leo StoneOther role · Director at Solid Biosciences, filing Form 4 there in the last year
PERCEPTIVE ADVISORS LLCDirector · Director and 10% owner at Solid Biosciences, filing Form 4 there in the last year
Sukumar NagendranPresident and Head of R&D · Director at Solid Biosciences, filing Form 4 there in the last year